Search

everythinglearnresearchcommunity

for

Search:↓

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Targeted cancer therapies often cause serious skin problems that need careful management.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Docetaxel is safe and works well for older people with cancer, with manageable side effects.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Blocking the Wnt pathway could lead to new treatments for cancer and tissue repair but requires careful development to avoid side effects.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.

Gene therapy shows promise for treating skin disorders and cancer, but faces technical challenges.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

Metformin, a diabetes drug, may also help fight cancer, but more research is needed to understand how.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Liposomal systems show promise for delivering drugs through the skin but face challenges like high costs and stability issues.

Eph/ephrin signaling is important for skin cell behavior and could be targeted to treat skin diseases.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

High levels of ST14 and TMEFF1 proteins in ovarian cancer are linked to worse patient outcomes and may be a new treatment target.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Pemetrexed is as effective as docetaxel but has fewer side effects for treating nonsmall-cell lung cancer after EGFR-TKI therapy failure.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.